
OriginElle International Symposium on Reproductive Medicine (OISRM 2026)
🎯 Selling to this event's audience? Get a free tailored buyer list
Tell us your work email and our AI instantly builds a buyer list matched to OriginElle International Symposium on Reproductive Medicine (OISRM 2026) — the best‑fit companies to target, the exact decision‑maker job titles, and the industry filters that fit what you sell.
About this event
OriginElle International Symposium on Reproductive Medicine (OISRM 2026)
Event type: Reproductive medicine, fertility care, IVF, women’s health, obstetrics & gynecology, embryology, laboratory medicine, clinical education, medical devices, pharmaceuticals, digital health, and healthcare networking.
Overall buyer value: High-value, specialized medical audience with strong B2B relevance for fertility clinics, women’s health providers, diagnostics companies, pharmaceutical brands, medical device vendors, laboratory solution providers, digital health platforms, and healthcare education/training businesses.
This symposium is likely to attract a focused group of decision-makers and influencers who are directly involved in reproductive medicine and adjacent healthcare categories. For attendee-list strategy, this event is more valuable for high-intent medical buyers than for broad general healthcare outreach. The best results typically come from targeting clinic owners, physicians, medical directors, embryology/lab leaders, procurement heads, fertility program managers, hospital department leaders, and commercial teams from companies serving reproductive health.
1️⃣ Who attends: Buyers / attendees
OISRM 2026 is expected to draw a professional audience centered around reproductive medicine and fertility-related care. The strongest buyer profiles are not general consumers, but rather clinical and commercial professionals with authority, influence, or strong purchasing intent.
Primary attendee groups:
- Reproductive endocrinologists
- Obstetricians and gynecologists
- Fertility clinic owners and medical directors
- Embryologists and IVF laboratory managers
- Andrologists and lab scientists
- Women’s health specialists
- Nurses, nurse practitioners, physician assistants, and care coordinators
- Hospital fertility program managers
- Procurement managers and supply chain leaders in healthcare
- Medical affairs, sales, and marketing teams from pharma and med-tech companies
- Healthcare educators, researchers, and academic faculty
- Clinical operations leaders
- Telehealth and fertility platform executives
- Insurance and benefits decision-makers focused on fertility coverage
Buyer interpretation: Many attendees will not be “buyers” in the strict procurement sense, but they are often strong influencers or specifiers. In this category, the true buyer can be the physician, clinic owner, lab director, administrator, or commercial leader who can approve, recommend, or influence products and services such as fertility medications, lab equipment, imaging, cryopreservation systems, diagnostics, patient engagement software, and clinic workflow tools.
2️⃣ Where the show is happening + attendee geographic origin
Venue/location: The event title alone does not confirm the city or country. Before final buyer targeting, the venue should be verified because geographic location strongly changes the attendee mix and outreach strategy.
Likely attendee origin pattern: Reproductive medicine symposia often have a strong regional/national base with selective international attendance, especially when the event is positioned as an “international symposium.” The audience may include:
- Local and national fertility specialists
- Regional clinic groups and hospital systems
- International speakers, researchers, and specialist vendors
- Global companies with reproductive health product portfolios
- Medical travelers, academic collaborators, and association members
Geographic targeting approach: If the event is in a major medical hub, the attendee base may be broader and more international. If it is in a single-country market, the strongest list value will likely come from local and national clinics, hospitals, and distributors with a relevant regional footprint.
3️⃣ Audience reach: Local / National / Global
Reach type: National to Global
This event appears to be positioned as an international-level professional symposium, which means the audience can extend beyond one country if the speaker lineup, scientific sessions, and sponsor base are strong. For outreach and list monetization, this makes the event attractive because it can support:
- Local reach for clinics and hospitals near the venue
- National reach for fertility centers, healthcare systems, and industry vendors across the country
- Global reach if the symposium attracts international faculty, sponsors, and premium healthcare brands
Practical takeaway: For attendee-list buyers, the value is highest when the event attracts decision-makers from multiple cities, leading fertility specialists, lab leaders, and vendor companies. This is especially useful for companies selling premium medical products, lab systems, advanced diagnostics, and fertility platforms.
4️⃣ Sample buyer company names + websites
Below is a targeted sample buyer table with companies that are commonly relevant to reproductive medicine, women’s health, fertility care, diagnostics, and medical technology. These are the kinds of accounts worth extracting and qualifying for outreach, depending on your client’s product and the event’s exhibitor/speaker ecosystem.
| Priority | Company | Website | Best Title to Target | Why This is a Good Buyer Fit |
|---|---|---|---|---|
| 1 | Merck | merck.com | Medical Affairs Manager, Fertility / Brand Manager, Reproductive Health | Strong pharmaceutical relevance in reproductive medicine and fertility-related therapies. |
| 2 | Organon | organon.com | Women’s Health Market Manager / Medical Director | Focused on women’s health and reproductive health commercial strategy. |
| 3 | Ferring Pharmaceuticals | ferring.com | Global Product Manager, Fertility / Regional Sales Director | Highly relevant fertility and reproductive health portfolio. |
| 4 | Cook Medical | cookmedical.com | Product Manager, Women’s Health / Clinical Specialist | Medical devices and clinical solutions can align well with fertility and OB-GYN workflows. |
| 5 | CooperSurgical | coopersurgical.com | Business Development Manager / Product Marketing Manager, IVF | Directly tied to fertility, reproductive health, and IVF lab tools. |
| 6 | Vitrolife | vitrolife.com | Regional Sales Manager / IVF Lab Specialist | Strong IVF and embryo culture/lab solutions fit. |
| 7 | Igenomix | igenomix.com | Commercial Director / Business Development Manager | Genetics and fertility testing are core buyer themes for this audience. |
| 8 | AbbVie | abbvie.com | Medical Science Liaison / Brand Manager, Women’s Health | Women’s health and specialty medicine teams often engage with reproductive health communities. |
| 9 | Thermo Fisher Scientific | thermofisher.com | Sales Manager, Life Sciences / Laboratory Solutions Specialist | Lab instruments, reagents, and diagnostics have strong IVF and reproductive research use cases. |
| 10 | Abbott | abbott.com | Hospital Sales Manager / Diagnostics Product Manager | Diagnostics and women’s health testing align with reproductive care pathways. |
| 11 | Siemens Healthineers | siemens-healthineers.com | Regional Sales Manager / Clinical Applications Specialist | Imaging, diagnostics, and women’s health solutions can support fertility and OB-GYN settings. |
| 12 | BD (Becton, Dickinson and Company) | bd.com | Product Manager / Sales Director, Healthcare Systems | Lab and clinical workflow solutions are relevant to hospital and fertility center buyers. |
| 13 | Hologic | hologic.com | Women’s Health Sales Manager / Clinical Education Manager | Well aligned with women’s health, diagnostics, and clinical education audiences. |
| 14 | Myriad Genetics | myriad.com | Account Executive, Clinical Genomics / Market Access Manager | Genetic testing and family planning relevance for reproductive medicine decision-makers. |
| 15 | Progyny | progyny.com | Employer Solutions Director / Strategic Partnerships Manager | Fertility benefits and employer healthcare programs are highly relevant to this audience. |
| 16 | Kindbody | kindbody.com | Clinic Growth Manager / Partnerships Director | Fertility clinic network with strong interest in patient acquisition and partnerships. |
| 17 | RMA Network | rmanetwork.com | Practice Administrator / Director of Operations | Large fertility practice with purchasing and operational needs in the category. |
| 18 | IVI RMA Global | ivirma.com | Global Medical Affairs / Business Development Director | International fertility network with strong relevance to symposium attendees. |
| 19 | Boston IVF | bostonivf.com | Clinical Director / Practice Administrator | Large fertility center where clinical and operational buyers matter. |
| 20 | Prelude Fertility | preludefertility.com | VP, Operations / Director of Purchasing | Multi-site fertility group with strong budget and vendor evaluation potential. |
Top sample accounts to lead with: Ferring Pharmaceuticals, Organon, Merck, CooperSurgical, Vitrolife, Thermo Fisher Scientific, Hologic, and Progyny. These are more likely to have direct relevance to reproductive medicine, fertility, diagnostics, lab systems, and patient care workflows.
5️⃣ Job profiles, industries & event type
The best job titles to target are those with clinical, operational, scientific, or commercial influence in reproductive medicine. This is not a broad consumer event; it is a specialist professional environment.
Best job profiles to target:
- Reproductive Endocrinologist
- OB-GYN Physician
- Medical Director, Fertility Clinic
- Clinic Owner / Practice Owner
- IVF Laboratory Director
- Embryology Manager
- Laboratory Manager
- Women’s Health Medical Director
- Director of Clinical Operations
- Director of Nursing
- Chief Medical Officer
- Procurement Manager, Healthcare
- Director of Business Development
- Product Manager, Reproductive Health
- Medical Science Liaison
- Regional Sales Manager, Diagnostics
- Market Access Manager
- Partnerships Director
- Hospital Department Head, OB-GYN
- Research Scientist, Reproductive Biology
Recommended industry filters:
- Hospital & Health Care
- Medical Practice
- Biotechnology
- Pharmaceuticals
- Medical Devices
- Research
- Higher Education
- Health, Wellness & Fitness
- Information Technology & Services
- Internet
- Staffing & Recruiting
- Management Consulting
- Market Research
- Insurance
- Financial Services
Additional useful industry choices from your list for this event: Biotechnology, Pharmaceuticals, Medical Devices, Hospital & Health Care, Medical Practice, Research, Information Technology & Services, Health, Wellness & Fitness, Insurance, and Higher Education.
6️⃣ Estimated attendance / expected footfall
Because the event title indicates a symposium rather than a large consumer expo, the attendance will likely be more selective and more qualified than a mass-market conference. A reasonable estimate would depend on venue, speaker lineup, and sponsor strength.
Estimated attendance range: 300 to 1,500 attendees
Typical footfall pattern:
- High concentration of specialists and clinicians
- Moderate number of commercial exhibitors and sponsors
- Strong networking among niche medical professionals
- Potentially smaller but higher-quality list compared with large general health conferences
Why this matters: Even if the total audience is not massive, the quality of the audience can be excellent for B2B lead generation. In reproductive medicine, a smaller audience can outperform larger events if the attendees are the exact stakeholders your client wants.
7️⃣ Key focus areas & buyer engagement
For a symposium like this, the engagement value comes from clinical education, scientific exchange, product demonstration, and relationship building. Buyers are often looking for trusted solutions rather than broad sales messages.
Key focus areas likely to be covered:
- IVF and assisted reproductive technology
- Embryology and embryology lab workflows
- Fertility preservation
- Genetics and preimplantation testing
- Women’s health and hormonal care
- Clinical diagnostics and lab testing
- Cryopreservation and specimen handling
- Patient experience and care coordination
- Digital fertility platforms and telehealth
- Regulatory, quality, and compliance issues
- Practice growth, patient acquisition, and payer strategy
- Research, education, and innovation in reproductive medicine
Buyer engagement angles that work well:
- Clinical outcomes
- Workflow improvement
- Cost efficiency
- Patient experience
- Laboratory precision
- Practice growth
- Evidence-based product performance
- Training and onboarding support
- Partnership opportunities with specialty clinics and hospital systems
Best messaging approach: Instead of saying “conference attendee list,” position it as access to fertility and reproductive health decision-makers, clinic operators, lab leaders, and women’s health commercial teams.
8️⃣ Client-product fit note
To identify the best buyers for this event, I need to review your client’s website first. The right audience depends heavily on what your client sells.
Please share your client website so I can review it and tell you the best buyer segments. Once I see the website, I can narrow this event down into the most relevant targets such as:
- Fertility clinics and practice groups
- OB-GYN hospitals and women’s health networks
- Pharmaceutical brands
- Medical device manufacturers
- IVF lab suppliers
- Diagnostics and genetic testing firms
- Healthcare software and patient engagement companies
- Insurance and fertility benefits providers
Example of how buyer fit changes by product:
- If your client sells lab equipment or consumables, the best targets are IVF lab directors, embryologists, fertility clinic owners, and hospital lab managers.
- If your client sells fertility drugs or specialty pharma services, the best targets are medical affairs teams, physician leaders, and women’s health commercial teams.
- If your client sells software / CRM / patient engagement tools, the best targets are clinic administrators, operations heads, and patient experience leaders.
- If your client sells diagnostics or genetic testing, the best targets are reproductive endocrinologists, lab directors, and clinical decision-makers.
9️⃣ Final recommendation
OISRM 2026 appears to be a strong niche event for attendee-list sales if your client serves reproductive medicine, fertility care, women’s health, lab medicine, diagnostics, pharmaceuticals, or medical devices. The quality of buyer data should be more important than the raw size of the event.
Best buyer categories to extract:
- Fertility clinic owners and medical directors
- Reproductive endocrinologists and OB-GYN specialists
- IVF laboratory leaders and embryologists
- Hospital women’s health department heads
- Pharma and med-tech commercial teams
- Healthcare procurement and operations leaders
- Research and academic faculty in reproductive biology
Quality rating for B2B attendee-list sales: 8.5/10
This is a strong specialized medical event with high relevance to premium healthcare buyers. The biggest advantage is the concentration of niche professionals who often influence purchasing decisions. The main caution is that not every attendee will be a direct buyer, so filtering by title, company type, and product fit is essential.
Next step: Please share your client website, and I will review it and give you the best buyers for this event based on your client’s exact product and ideal customer profile.
Data sheet
| Event Name | OriginElle International Symposium on Reproductive Medicine (OISRM 2026) |
| Event Date | 3 July 2026 – 5 July 2026 |
| Event Status | Upcoming |
| Venue | Royal Society of Medicine |
| City | London |
| State / Region | England |
| Country | United Kingdom |
| Organizer | Not publicly confirmed in the materials available for this review. |
| Official Event Website | Not publicly verified in the materials available for this review. |
| Event Type | Medical symposium / clinical education and specialist healthcare networking event focused on reproductive medicine, fertility care, IVF, embryology, women’s health, laboratory medicine, medical devices, pharmaceuticals, and digital health. |
| Primary Category | Medical & Pharma |
| Secondary Applicable Categories | Wellness, Health & Fitness; Science & Research; IT & Technology |
| Audience Reach | Likely national-to-international specialist medical audience, based on the event title and subject matter. Current-year reach details not publicly confirmed. |
| Estimated Attendance / Expected Footfall | Attendance figure not publicly confirmed by the organizer. |
| Attendance Data Reliability | Low for volume metrics; event name, date, venue, city, region, and country were provided for this review. No official current-year attendance dataset was publicly verified in the available materials. |
| Main Purpose of Event | To convene reproductive medicine clinicians, fertility specialists, embryology and laboratory leaders, women’s health stakeholders, researchers, solution providers, and commercial partners for education, networking, clinical updates, and supplier engagement. |
OriginElle International Symposium on Reproductive Medicine (OISRM 2026) appears to be a specialist healthcare symposium centered on reproductive medicine, fertility care, IVF, women’s health, embryology, and associated laboratory and clinical disciplines. Based on the event title, format, and venue profile, it is best understood as a focused professional meeting rather than a broad consumer health exhibition.
From a B2B perspective, the event is relevant because reproductive medicine is a high-value specialty with purchasing influence across clinics, hospitals, diagnostic laboratories, device procurement, pharmaceutical prescribing, digital health adoption, and continuing clinical education. Even without a public attendee list, the event profile suggests strong lead-generation relevance for suppliers targeting specialist medical decision-makers, program leaders, and senior clinical influencers.
| Buyer / Attendee Segment | Typical Organizations | Buying Role or Influence | Relevance to Exhibitors / Suppliers |
|---|---|---|---|
| Fertility clinic owners and executives | Private fertility clinics, IVF groups, reproductive health networks | Budget approval, service expansion, vendor selection | High-value buyers for equipment, diagnostics, software, consumables, and training |
| Reproductive medicine physicians | IVF centers, hospitals, women’s health departments, specialist practices | Clinical influence, product evaluation, protocol adoption | Key influencers for diagnostics, pharmaceuticals, devices, and digital tools |
| Medical directors and department heads | Fertility programs, hospital reproductive medicine units | Clinical governance, vendor approval, strategic purchasing influence | High relevance for enterprise-level supplier positioning |
| Embryology and laboratory leaders | Embryology labs, IVF laboratories, pathology and diagnostics teams | Technical specification input, workflow decisions, lab procurement influence | Critical for lab instruments, consumables, media, QC systems, and automation tools |
| Hospital procurement and sourcing teams | NHS trusts, private hospital groups, specialty hospitals | Commercial review, contracting, vendor onboarding | Relevant for devices, diagnostics, facilities solutions, and managed services |
| Women’s health program managers | Clinic groups, hospital service lines, care pathways teams | Program implementation, patient service optimization | Good targets for digital health, patient engagement, scheduling, and workflow tools |
| Pharmaceutical and medical affairs stakeholders | Pharma companies, fertility therapeutics brands, specialty healthcare firms | Partnerships, KOL engagement, therapy awareness | Relevant for co-promotion, education, and market access initiatives |
| Diagnostics and laboratory procurement teams | Clinical labs, fertility testing providers, pathology service groups | Purchasing and validation of testing solutions | High fit for assay providers, instrumentation suppliers, and LIMS vendors |
| Healthcare technology leaders | Clinics, hospitals, digital health companies, fertility platforms | IT adoption, platform integration, data governance | Relevant for EMR, CRM, telehealth, AI, imaging, and analytics solutions |
| Researchers and academic specialists | Universities, teaching hospitals, research institutes | Evaluation influence, trial activity, innovation partnerships | Important for pilot projects, validation studies, and thought leadership |
| Geographic Area | Likely Attendee Origin | Buyer Concentration | Notes |
|---|---|---|---|
| London | High likelihood of local attendance from major private clinics, specialist hospitals, academic hospitals, and women’s health providers | High | Host city is a major healthcare, academic, and international travel hub |
| England | Likely attendance from fertility clinics, NHS trusts, private hospital groups, and laboratory providers across England | High | London-based medical events often draw strong participation from surrounding regional healthcare networks |
| United Kingdom | Likely national reach including Scotland, Wales, and Northern Ireland for specialist reproductive medicine professionals | Medium to High | National specialty events commonly attract cross-UK clinical audiences when the topic is niche and high-value |
| Western Europe | Possible attendance from fertility and research professionals in nearby European markets | Medium | The word “International” indicates potential cross-border participation, but current-year country data is not publicly confirmed |
| Broader international markets | Possible attendance from global reproductive medicine specialists, researchers, and commercial stakeholders | Medium | International relevance is likely, but no verified current-year attendee geography breakdown was found in the available materials |
| Reach Level | Assessment | Explanation |
|---|---|---|
| National | Primary classification | The London location, specialist medical topic, and symposium format indicate strong UK-wide relevance for reproductive medicine professionals. |
| International | Secondary likely reach | The event title includes “International,” suggesting cross-border appeal, but current-year attendee country evidence was not publicly confirmed. |
| Buyer Company / Organization | Buyer Type | Why It Is Relevant | Website | Best Job Titles to Target | Evidence Level |
|---|---|---|---|---|---|
| Official current-year buyer / attendee organizations | Not publicly listed | No official attendee, sponsor, exhibitor, or speaker organization list was publicly verified in the materials available for this review. | Not publicly verified | Medical Director; Clinic Director; Head of Embryology; Procurement Manager; Director of Women’s Health; Laboratory Manager | Confirmed data unavailable |
| Priority | Job Title / Function | Department | Seniority Level | Why This Role Matters |
|---|---|---|---|---|
| 1 | Medical Director | Clinical Leadership | Director / Executive | Owns clinical direction, treatment standards, and product adoption influence |
| 2 | Clinic Director / Practice Director | Operations | Director | Controls operational budgets, workflow choices, and supplier relationships |
| 3 | Head of Embryology | Laboratory / Clinical | Head / Director | Highly influential for lab systems, consumables, incubators, imaging, and quality control |
| 4 | Laboratory Manager | Laboratory | Manager | Manages day-to-day purchasing, implementation, validation, and process optimization |
| 5 | Director of Procurement | Procurement | Director | Important for contracting and vendor approval in larger providers and hospital systems |
| 6 | Procurement Manager | Procurement | Manager | Relevant for tenders, sourcing, supplier onboarding, and spend review |
| 7 | Director of Women’s Health | Clinical Services | Director | Relevant for strategic service-line decisions and technology adoption |
| 8 | Program Manager, Fertility Services | Operations / Programs | Manager | Useful for implementation-led solutions and patient workflow tools |
| 9 | Chief Medical Officer | Executive Leadership | C-Level | Senior strategic influence at multi-site provider groups and healthcare platforms |
| 10 | IT Director / Digital Health Lead | Information Technology | Director / Head | Relevant for patient software, interoperability, analytics, telehealth, and security platforms |
| Priority | Apollo Industry | Why It Fits the Event | Best Buyer Use Case |
|---|---|---|---|
| 1 | Hospital & Health Care | Core fit for clinics, hospitals, and specialist care providers | Clinical buyers, department heads, operations leaders |
| 2 | Medical Practice | Strong fit for physician-led fertility and women’s health practices | Clinic owners, practice administrators, physicians |
| 3 | Medical Devices | Relevant for fertility equipment, lab systems, imaging, and procedural tools | Supplier partnerships, channel outreach, KOL engagement |
| 4 | Pharmaceuticals | Strong alignment with fertility therapeutics and women’s health prescribing environments | Medical affairs, brand partnerships, specialist outreach |
| 5 | Biotechnology | Relevant to reproductive science, testing, innovation, and translational medicine | Research collaborations and advanced diagnostics targeting |
| 6 | Research | Fits academic and clinical research institutions active in reproductive medicine | Trial support, validation, grants, partnerships |
| 7 | Higher Education | Relevant for medical schools and teaching hospitals | Academic partnerships and training programs |
| 8 | Information Technology & Services | Fits digital health, clinic workflow, data, and patient engagement platforms | Software sales and integration-led outreach |
| 9 | Computer Software | Useful for fertility management systems, scheduling, analytics, and patient apps | Clinic and hospital digital transformation outreach |
| 10 | Health, Wellness & Fitness | Secondary fit for women’s health and patient-support ecosystems | Consumer-facing service and partnership targeting |
| Metric | Figure | Status | Source / Basis | Notes |
|---|---|---|---|---|
| Estimated total footfall | Attendance figure not publicly confirmed by the organizer. | Unconfirmed | No public current-year attendance disclosure verified | No reliable attendee volume should be used for list-sales claims |
| Exhibitor count | Not publicly confirmed | Unconfirmed | No public exhibitor directory verified | Symposium format may rely more on sponsors and partners than broad expo booths |
| Buyer count | Not publicly confirmed | Unconfirmed | No official buyer program or registration segmentation verified | Specialist medical events usually attract high-value buyers even at smaller scale |
| Speaker count | Not publicly confirmed | Unconfirmed | No agenda or faculty page publicly verified in the available materials | Speaker organizations would materially improve targeting quality if published later |
| Sponsor count | Not publicly confirmed | Unconfirmed | No public sponsor listing verified | Sponsor evidence would help identify commercial-side attendees and partners |
| Historical attendance | Not publicly confirmed | Historical data unavailable | No prior-year official attendance statistics verified | Historical benchmarking should not be assumed without organizer evidence |
| Focus Area | Typical Buyer Need | Buyer Engagement Opportunity | Relevant Supplier Offering |
|---|---|---|---|
| Reproductive medicine | Clinical effectiveness, treatment protocols, patient outcomes | KOL-led education, evidence-based product positioning | Clinical technologies, diagnostics, therapeutic support, education platforms |
| Fertility care and IVF | Process efficiency, success rates, patient experience | Direct clinic outreach and service-line solution selling | IVF equipment, patient management software, treatment support services |
| Embryology and laboratory medicine | Lab precision, quality control, workflow reliability | Technical demos and lab-led consultative selling | Lab instruments, consumables, imaging systems, QC tools, LIMS |
| Women’s health | Integrated care, pathway improvement, specialist service growth | Cross-functional clinical and operational conversations | Care platforms, diagnostics, support programs, service optimization tools |
| Medical devices | Equipment performance, compliance, ROI | Clinical validation and procurement-led evaluation | Procedure devices, imaging, monitoring, lab hardware |
| Pharmaceuticals | Therapy awareness, prescribing support, clinical evidence | Medical affairs and specialist physician engagement | Fertility drugs, adjunct therapeutics, educational support |
| Digital health | Patient communication, digital workflows, analytics, telehealth | IT and operations conversations with measurable efficiency value | Software, CRM, scheduling, telemedicine, AI, data dashboards |
| Clinical education and networking | Continuing education, benchmarking, peer exchange | Thought leadership, workshop sponsorship, faculty engagement | Training services, CME support, advisory partnerships |
| Factor | Assessment | Explanation |
|---|---|---|
| Buyer relevance | Very High | The subject matter points to a concentrated specialty audience with direct need for clinical, lab, pharma, and digital health solutions. |
| Decision-maker availability | High | Specialist symposia typically attract senior clinical and operational stakeholders rather than junior generalist attendees. |
| Data collection potential | Medium | Potential is strong if agenda, faculty, sponsors, and partner lists are published; currently limited by lack of verified participant directories. |
| Apollo targeting potential | High | The buyer universe can be targeted well using healthcare, medical practice, devices, pharmaceuticals, and digital health filters. |
| Geographic targeting potential | High | London and wider UK specialist reproductive medicine markets are practical for localized outreach and ABM campaigns. |
| Best outreach approach | High | Educational and consultative outreach works best, especially around patient outcomes, lab quality, efficiency, and compliance. |
| Overall lead quality | High | Although volume is unconfirmed, the likely attendee profile is specialized and commercially valuable. |
| Best use case | High | Best for high-intent medical buyer targeting, ABM prospecting, sponsor outreach, and specialist healthcare partnerships. |
| Limitations / risks | Medium | Current-year participant verification is limited. It should not be positioned as a confirmed attendee-list opportunity until official participant evidence appears. |
| Filter Type | Recommended Filters | Purpose |
|---|---|---|
| Apollo industries | Hospital & Health Care; Medical Practice; Medical Devices; Pharmaceuticals; Biotechnology; Research; Higher Education; Information Technology & Services; Computer Software; Health, Wellness & Fitness | Covers the core clinical, laboratory, product, research, and digital health ecosystem |
| Departments | Operations; Medical & Health; Information Technology; Purchasing; Program & Project Management; Business Development | Focuses on clinical decision-makers and purchasing influencers |
| Seniority | Owner; Founder; Partner; C-Level; VP; Director; Head; Manager | Prioritizes individuals with authority over budgets, adoption, and vendor selection |
| Job titles | Medical Director; Clinic Director; Clinical Director; Practice Director; Head of Embryology; Laboratory Manager; IVF Director; Fertility Program Manager; Director of Women’s Health; Procurement Manager; Director of Procurement; Chief Medical Officer; IT Director; Digital Health Lead | Pinpoints the most commercially useful titles for specialist reproductive medicine outreach |
| Geography | United Kingdom first; London and South East England priority; optional expansion to Ireland and Western Europe | Aligns with likely attendee origin and practical follow-up markets |
| Employee size | 11–50; 51–200; 201–500; 501–1000; 1001–5000+ | Captures both private clinics and larger hospitals / provider groups |
| Keywords | fertility, IVF, reproductive medicine, embryology, women’s health, assisted reproduction, fertility clinic, ART lab, reproductive health, gynecology | Improves title and company relevance in niche market segments |
| Technologies | Use when relevant: EHR/EMR, LIMS, telehealth, CRM, analytics, patient portal | Useful for digital-health vendors and integration-led prospecting |
| Revenue range | Optional; prioritize mid-market to enterprise for medical devices and software, and SMB to mid-market for private clinics | Helps segment enterprise hospital groups from specialist clinic operators |
| Company type | Private clinics, hospital groups, specialist medical practices, diagnostic labs, academic medical centers, healthcare technology providers | Builds a practical target account list aligned with the event theme |
| Source | Type | What It Verified | Reliability |
|---|---|---|---|
| User-provided event brief | Provided input | Event name, dates, city, region, country, venue, and thematic description used for this datasheet | Medium |
| Royal Society of Medicine | Official venue website | Venue identity and relevance as a London medical meeting location | High |
| Public current-year event website / attendee directory | Verification status | Not publicly verified in the materials available for this review; no confirmed attendee, sponsor, exhibitor, or speaker list was found in the source set used here | Low / unavailable |
🎯 Selling to this event's audience? Get a free tailored buyer list
Tell us your work email and our AI instantly builds a buyer list matched to OriginElle International Symposium on Reproductive Medicine (OISRM 2026) — the best‑fit companies to target, the exact decision‑maker job titles, and the industry filters that fit what you sell.